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Abstract: The c-Jun N-terminal Kinases (JNKs) are a group of regulatory elements responsible for the
control of a wide array of functions within the cell. In the central nervous system (CNS), JNKs are
involved in neuronal polarization, starting from the cell division of neural stem cells and ending with
their final positioning when migrating and maturing. This review will focus mostly on isoform JNK1,
the foremost contributor of total JNK activity in the CNS. Throughout the text, research from multiple
groups will be summarized and discussed in order to describe the involvement of the JNKs in the
different steps of neuronal polarization. The data presented support the idea that isoform JNK1 is
highly relevant to the regulation of many of the processes that occur in neuronal development in
the CNS.
Keywords: JNK1; migration; asymmetric division; synaptogenesis; NMDAR; WDR62; SCG10;
MAP1B; DCX
1. Introduction
Proper neuronal development is essential to the correct functioning of brain networks and
connections. Due to its biological relevance, brain development is a controlled process that includes
multiple regulatory pathways and mechanisms.
c-Jun NH2-terminal Kinases (JNKs), also known as Stress-Activated Protein Kinases, are a
group of stimuli-response enzyme members of the Mitogen-Activated Protein Kinase (MAPK)
family [1,2]. In mammals, JNK isoforms are codified in three different genes: Jnk1/Mapk8, Jnk2/Mapk9,
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and Jnk3/Mapk10, which express four splice variants for JNK1 (α1, α2, β1, β2), four variants for JNK2
(α1, α2, β1, β2), and ~8 variants for JNK3 (less characterized), all having a molecular weight of either
46 (p46, α1 and β2) or 54 KDa (p54, α2 and β2) with a C-terminal extension; additionally, some splice
variants of JNK3 have an N-terminal extension [3–5]. Nonetheless, isoforms exhibit specific patterns of
distribution in the organism, e.g., JNK1 and JNK2 are ubiquitous while JNK3 is only expressed in the
heart, testicles and brain. Some organelles (such as mitochondria and endoplasmic reticulum) and
structures (such as dendritic spines and axon terminals) show special enrichment of JNKs, usually in
an isoform-specific manner. These data suggest that every isoform has different regulatory functions,
vanquishing the notion of redundancy [3,4].
Different JNKs phosphorylate a wide arrange of nuclear and cytosolic substrates in serine/threonine
residues, followed by proline residue, thereby underpinning their role in critical physiological processes
that include neuronal functions and immunological responses, together with embryonic and postnatal
development [4–6]. This is evidence of the highly differentiated regulatory functions of JNK isoforms [7].
In this review, we will discuss reports focused on isoform JNK1. Evidence has identified it as an
essential protein in the orchestrated process of global brain development. Notably, no developmental
illness has been reported to be caused by genetic mutations of the JNK1 isoform; instead, there is a large
body of associative evidence. Surprisingly, this is not the case for its cytosolic substrates, such as MAP1B,
MAP2, WRD62, DCX and SCG10, which, in case of impairment, can trigger neurodevelopmental
disorders such as microcephaly, lissencephaly, band heterotopia, cortical dysplasia and intellectual
disabilities [8–13].
1.1. The JNKs Signaling Cascade
In the central nervous system (CNS), JNK signaling regulates many cellular processes, ranging from
morphogenesis, neuronal pathfinding, axodendritic architecture, neuronal survival, synaptic plasticity
and memory formation, as well as energetic and hormonal regulation [11,13–16].
JNKs are prodirected serine/threonine kinases; their activation occurs in a three-step cascade of
kinases, starting with the Kinase Kinase (MAPKKKs). MAPKKKs phosphorylate and activate members
of the MAPK Kinase family (MAPKK), such as MAPK/ERK Kinase 4 (MKK4) and MAPK/ERK Kinase 7
(MKK7) which, in turn, activate MAPKs (JNK1/SAPK1, JNK2/SAPK2, and JNK3/SAPK3) in conserved
dual phosphorylation sites of threonine and tyrosine (TPY motif sequence). Scaffold JNK-interacting
proteins (JIP) facilitate the sequential phosphorylation cascade and MAPK phosphatases (MKPs)
deactivate this pathway [5,17–19].
The protein structure of JNK has two globular domains which are characterized by a short
N-terminal and large C-terminal peptide chain connected by a flexible domain, i.e., the catalytic site
present in a deep cleft domain on the interface of lobules. Their mechanism of the action comprises
multiple steps, starting with their acquisition of an open conformation in the absence of ATP, and a
closed conformation when activated and bound with the substrate [20]. Several motifs are necessary
to regulate the enzymatic reaction: the activation domain (A-loop) contains the TPY sequence, and a
conserved G-loop (Glycine-Rich) motif is necessary to close the ATP-binding domain. The HRD motif
is involved in the reaction mechanics; meanwhile, the DRG sequence is critical for conformational
changing in the reaction [20,21]. JNKs also contain D-recruiting site (DRS). This sequence is necessary
for interactions with their cognate sequence D-motif, found in substrates or scaffold-protein-like
JIP [21]. In general, the catalytic site is conserved (See protein alignment for the main JNK isoform,
Supplementary Materials Table S1)
Disruptions of physiological signaling of the JNKs may lead to adverse outcomes, both when
the pathway is down- or up- regulated. For example, there is evidence that links dysregulations
in the signaling of the JNK pathway with neurodegenerative diseases including Parkinson’s [22],
Alzheimer’s [23] and Huntington’s diseases [24,25], polyglutamine diseases [26] and auditory hair cell
degeneration [27]. Moreover, defects in JNK activation, with a key role in axonal growth, explain the
neurodevelopmental deficits that appear in lysosomal storage diseases [1,3,4,28]. In line with this,
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genetic studies in patients have associated truncated mutation of JNK3, induced by translocation in
chromosome 4 and Y, with severe developmental epilepsy and intellectual disability. This mutation
prompts the of loss-of-function of the JNK signaling pathway, preventing the phosphorylation of
the classical JNK target c-Jun and other substrates such as PSD95 [29,30]. Moreover, other studies
have shown that changes in physiological signaling of the MKK7/JNK cascade may underlie the
neurochemical alterations which are associated with schizophrenic symptoms [31]. Genetic association
studies have linked schizophrenia with the microduplication of several genes, including TAO2 kinase,
an upstream activator of the JNKs [32]. Finally, mice knockout of Jnk1, or mice treated with an
engineered retrovirus that exclusively inhibited JNK1 in adult-born granule cells, displayed an increase
in immature neurons in the dentate gyrus of the hippocampus, an effect that has been correlated with a
reduction in depressive-like behaviors [33]. Our results provide evidence that a lack of Jnk1 in mice
offers neuroprotection against excitability and the cognitive impairments induced with high fat diets
(HFD) [34].
1.2. Cytosolic Substrates of JNK in Developing Neurons
Over the years, biochemical studies have allowed us to identify multiple substrates to JNKs
located in the cytoplasm or nucleus. In the nucleus, JNKs regulate multiple transcription factors
which are responsible for gene expression, e.g., c-Jun, activating transcription factor 2 (ATF2),
E26 transformation-specific-like 1 (Elk-1), p53, nuclear factor of activated t-cells 4 (NFAT4) and
other chromatin modifiers [3]. However, bioinformatic studies of D-motifs have revealed that multiple
JNK substrates may comprise cytoskeletal proteins such as actin-binding proteins, microtubule-binding
proteins (MAPs), motors proteins, centrosomal proteins, basal bodies and others involved in primary
cilium biogenesis [5]. Functional analyses have confirmed that JNKs phosphorylate several MAPs,
including Microtubule-Associated Protein 1B (MAP1B), Microtubule-Associated Protein 2 (MAP2),
Microtubule Associated Protein Tau [35], Doublecortin (DCX) [36] and superior cervical ganglion
protein 10 (SCG10; also known as Stathmin 2 (STMN2) [37]. In fact, some estimates link JNK signaling
with at least 60% of the total phosphorylation occurring in the growth cone during brain development,
affecting substrates like the Growth Associated Protein 43 (GAP43), MAP1B, SCG10, RUN FYVE
Domain Containing 3 (RUFY3) and Roundabout Guidance Receptor 2 (ROBO2) [38].
Furthermore, single neurites accumulate mRNAs of elements belonging to the JNK pathway,
such as Jnk1, Mkk4, Mkk7, Dual Leucine Zipper Kinase (Dlk), a novel SCG10-like protein (Sclip),
Map2, Map1b, and Scaffold JNK-interacting protein family members, i.e., JipP4/JlpP and Jip3/JSap [39].
Local translation rates suggest a high turnover of JNK signaling components in neurites.
1.3. JNKs Have Specific Functions. JNK1 is Essential for Proper CNS Development
The different JNKs isoforms have specific functions and respond differently, according to the type
of stimulus, duration, cell or subcellular compartment [6,40]. In the CNS, JNK1 activity is the foremost
contributor to total JNK activity; it takes part in many processes, including in the maintenance of
axonal tracks during development or the control of cognitive function [4,28,41].
The use of knockout (KO) mice for the JNK1 isoform has given rise to reports that this isoform is
essential for proper CNS development. It was described that the absence of a single isoform is not lethal
in transgenic knockout mice, but that double null mutant embryos for JNK1 and JNK2 (Jnk1−/−Jnk2−/−)
die between embryonic day E11 and 12. These mice fail to close the neural tube due to a decrease
in apoptosis rate in the hindbrain neuroepithelium and an increase in the forebrain correlated with
widespread caspase activation. Furthermore, Jnk1-/-Jnk2-/+ mice present retinal coloboma (failure in
fissure closure) and show severe defects in the lens at E18. These mice die after birth due to severe
deficiencies in their development. These JNK isoforms play a different role in apoptosis, depending on
the brain region where they are located, suggesting that JNK1 and JNK2 have both proapoptotic and
apoptotic functions. Moreover, the absence of lethality in Jnk1−/−/Jnk3−/− or Jnk2−/−/Jnk3−/− embryos,
together with the lack of apoptotic alterations in these double mutant mice, suggests that JNK1 and
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JNK2, but not JNK3, have a redundant role in the regulation of apoptosis in specific brain areas during
brain embryogenesis [42,43].
Jnk1-/-Jnk2-/+ mice present retinal coloboma (failure in fissure closure) and show severe defects in
the lens at E18. These mice die after birth due to severe deficiencies in their development. Importantly,
while a partial expression of JNK2 is not enough to compensate for a lack of JNK1, monoallelic expression
of Jnk1 in Jnk1-/+Jnk2-/- knockout mice leads to a nonobvious altered phenotype which allows the animals
to survive [44]. Nonetheless, mice null for the Jnk1 gene have the anterior commissure disrupted
and exhibit alterations in the organization of cortical area, with no clear consensus regarding the
consequences of this. Chang et al. reported that these mice showed growing degeneration of axonal
and dendritic processes (visible in 8-month-old animals), jointly with progressive learning impairment
and motor defects [41,45,46]. Our research group observed no behavioral alterations when testing
9-month-old Jnk1-/- animals using the novel object recognition test [34].
1.4. JNKs Regulate Programmed Cell Death During Brain Development
Neuronal death is a highly conserved and relevant process in brain development that is controlled
by JNKs. It plays a role in the control of synaptic connections and morphogenesis, e.g., in the
elimination of defective and abnormal cells [47]. As Kuan et al. reported, the JNK signaling pathway
controls caspase activity in brain embryonic regions [43]. However, the mechanism of JNK activity in
programmed cell death during development remains under study. In this line, our results showed
a different number of immature neurons in the subgranular zone of the dentate gyrus of the adult
hippocampus in knockouts (KOs) for JNK compared with wild type (WT) [14]. However, the mechanism
of JNK activity in programmed cell death during development remains unclear. In this line, our results
showed a different number of immature neurons in the subgranular zone of the dentate gyrus of the
adult hippocampus in knockouts (KOs) for JNK, compared with wild type (WT) [47]. Since AGO is
highly conserved across both the animal and plant kingdom, the role of the AGO1-TAK1-JNK pathway
in programmed cell death in brain in mammalian development must be analyzed. In addition, it would
be useful to identify the role of canonical Wnt pathway signaling in programmed cell death in the CNS
in mammals, because Wnt signaling, in collaboration with the JNK pathway, promotes dorsal closure
and ventral patterning during Drosophila embryogenesis [48].
2. Polarization of Cell Division: JNK1 and Asymmetric Division of Neural Stem Cells
The polarization process in neurons is necessary during all stages of their life. At the beginning,
Neuronal Stem Cells (NCS) experience a polarized division to differentiate, and immature neurons
polarize their membrane projections to migrate, the last step of polarization occurs during axodendritic
biogenesis. These specific processes are forms of polarization regulated by JNKs.
The polarization of cell division is a requirement for the correct expansion and differentiation
of NSCs. Around E10, radial glial cells (cortical NSC) actively proliferate in the lateral ventricles.
These neural progenitors attach their plasma membrane in two subdomains: the apical membrane
facing the ventricular space and the basal facing the pia (Figure 1). The apical and basal membranes of
these cells represent less than 3% of the total contact; basolateral space confines the rest. The cells that
experience symmetric division preserve their capacity for self-renewal to maintain cellular population
(Figure 1A). However, during E12 and E15, NSCs may also start to divide asymmetrically, losing the
apicobasal contacts [49].
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1 
  Figure 1. JNK1 controls polarization of dividing cells. Radial-glial-like cells (cortical NSCs) are
located in the SVZ and show apicobasal polarization. The orientation of the mitotic spindle controls
symmetric and asymmetric divisions: (A) Symmetric division preserves self-renewal and expands radial
glial-like progeny, (B) Asymmetric division promotes the loss of apicobasal contact of daughter cells,
promoting their differentiation. The activity of the Par3/Par6/aPKC and Gαi-LGN-NuMa complexes
determines the orientation of the mitotic spindle. (C) The pericentriolar material of centrosome contains
both JNK1 and WDR62. Genetic disabling of this elements induces abnormal spindle formation and
aberrant centrosome biogenesis. Adapted from [50].
The activity of apical polarity molecules determines the plane of excision regulated by the
orientation of the mitotic spindle. These molecules are the Par protein cortical complex, which comprises
aPKC (atypical Protein Kinase C), the conserved PDZ domain proteins Bazooka (Par3) and Par6
(Par3/Par6/aPKC complex), and the Gαi-LGN-NuMa centrosomic complex. The mammalian homolog
of Drosophila Pins (LGN) functions as a conformational switch that links Gαi and the nuclear mitotic
apparatus (NuMA) protein. LGN and Gαi may exert forces on mitotic spindles during mammalian
cell division (Figure 1A,B) [50,51].
JNK1 is part of the centrosome, and reaches its maximum activity between the S-phase and the
late anaphase. Hence, JNK1 regulates cell cycle mechanisms in mitotic cells [52]. JNK1 colocalizes
with WDR62, a centrosomic protein with binding sites to upstream kinases such as MKK3/MKK7 and
JNK1 [53,54]. Over 30 mutations in WDR62 can cause forms of primary microcephaly, often accompanied
by agyria and cortical dysplasia [55].
The depletion of JNK1 and WDR62 induces abnormal spindle formation and aberrant centrosome
biogenesis in NSCs during corticogenesis (Figure 1C). Knockdown of Wr62 induced by the siRNA
electroporation in utero in embryo mice cortices impairs the cell division of NSCs. As a result,
NSCs reduce their population until exhaustion. The loss of self-renewal produces premature
differentiation and early departure of migratory neurons, observed with supernumerary accumulation
in the intermediate zone [8]. These defects resemble those seen in the developing cortices of Jnk1-/-
mice [56]. Importantly, an active constituent form of JNK1 rescues the phenotype [8,57].
Moreover, we observed in our research on adult hippocampal neurogenesis that Jnk1-/- mice
exhibited notable reductions of radial-glia like cells (hippocampal NSC). As a consequence, a shrinking
of the ventricle layers and an accumulation of neuroblasts was observed in the intermediate zone
of granule cell layers in the dentate gyrus [14]. These results agreed with observations made by Xu
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and colleagues [8]. In conclusion, it seems evident that JNK1 is relevant for asymmetrical division,
and therefore, that it regulates the proliferation, differentiation and migration of neurons in the cortex
and hippocampus. Nonetheless, diverse questions remain open in this field.
3. Neuronal Polarization
Neuronal membrane projections form dendrites and axons as part of a cell polarization program
that takes place after the birth of the neuron. Accumulated evidence shows that neural symmetry
breakage comprises two elements: an autonomous-independent cellular intrinsic mechanism and
extrinsic microenvironmental effectors (polarizing cues) [58–60].
Gary Banker and coworkers initially described the intrinsic mechanism using hippocampal
postmitotic neurons obtained from the brain of rat embryos at E18 [61]. They observed in their cultures
that neurons, successfully seeded, extend lamellipodia over the plate, for ~12 hours (Stage 1). Then,
sprouting of 4 to 5 neurites (Stage 2, or multipolar stage) arises. Subsequently, only a single “neurite”
experienced growth (Stage 3). From then on, it was determined that the longest neurite was the nascent
axon (axonogenesis). After axon elongation (7 days of culture), dendritogenesis occurred (Stage 4),
comprising the branching of the remaining neurites. Finally, spinogenesis and axonal branching
occurred in stage 5 (Figure 2) [62,63]. Now, research in this field is focused on disentangling the
mechanics of this process in vivo. For example, dendritogenesis is part of a developmental process
called synaptogenesis (Section 5), in which spine dendrites make contact with the axonal terminals.
 
Figure 2. Role of JNKs in neuronal polarization. (A–E): Phenotypic changes along neuronal polarization
in vitro. (A) (Stage 1) Embryonic hippocampal neurons extend the lamellipodia. Twelve hours later,
the breakage of neuron symmetry occurs. (B) (Stage 2) Neurons become multipolar. One neurite
is selected and experiences a positive feedback signal on its tip, which induces axon determination.
(C) (Stage 3, axonogenesis) Signal propagates to the soma (red), inducing the stabilization and elongation
of microtubules. The remaining neurites receive inhibitory signals (blue) (D) (Stage 4, Dendritogenesis)
After axon elongation, the remaining neurites are extended. (E) (Stage 5, Spinogenesis) Finally, spines and
axonal branching occur. (a–e) Molecular events that occur during neuronal polarization. (a) Axon
determination is induced by growth factors. Centrosome and Golgi apparatuses are recruited. (b) Rho
GTPases (Cdc42, Rac1) and the Par3/Par6/aPKC complex form a positive feedback circuit required
for axon determination. (c) The persistent activation of Rac1 and Cdc42 leads to JNK activation,
promoting neurite outgrowth through growth cones (red), while the activation of RhoA in minor
neurites leads to JNK deactivation (blue). (d) Dendritogenesis is stimulated by BMP7 through Bone
Morphogenic Protein Receptor (BMPR), Wnt7b through Frizzled receptor and Sema3A through Nrp1.
Dendrite homeostasis is controlled through SCG10, MAP and MARCKSL1 substrates that are activated
by JNK1 (red) (e) Spine density is regulated by substrates such as DCX and MARCKSL1, and axonal
branching is promoted by the deactivation of JNK1 through BDNF.
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3.1. Molecular Signalling Along Different Stages
A global-to-local activation–inhibition model explains the stereotypical behavior of neurons when
they break their cell symmetry. Positive feedback signaling is primed on a specific neurite. This signal
is propagated to the soma, inducing the stabilization and elongation of microtubules, and consequently,
favoring the differentiation of the axon (Stage 3). A negative feedback signal or self-inhibition of the
remaining neurites represses the formation of a second axon (Figure 2B,C) [59,64].
The nature of the cell signaling that precedes the sprouting of neurites remains unclear, as does
the involvement of JNKs in it. Nonetheless, the positioning of the centrosome and Golgi apparatuses,
and cell adhesion signaling induced by N-cadherin, play a pivotal role in determining cell symmetry
breakage, just like in axon determination [65–67] (Figure 2A). Regulatory activities of JNKs occur
mainly from stage 2 onwards.
3.2. Axon Determination
The involvement of JNK signaling in axon determination derives from early observations
in studies in PC12 and neuroblastoma cell lines [68–70]. Exposing growth factors to these cells
induced persistent activation of JNKs, resulting in their differentiation into neurons [68–70]. Also,
pharmacological JNK inhibition (SP600125) and genetic tools (constitutive active Jnk) supported
this notion. Subsequent experiments were extended to primary dorsal root ganglia explants [71]
and dopaminergic neurons [72], consolidating a formal theory on the involvement of the JNKs in
axon determination.
Relevantly, none of these experiments identified the involvement of a specific JNK isoform.
The following section describes specific cell signaling mechanisms that respond to growth factors,
and how they activate the JNKs.
3.2.1. Ras Homologous (Rho) GTPase Family
Several molecules take part in axon determination, like the Transforming Growth Factor-β (TGF-β),
Semaphorin3A (Sema3A), Insulin Growth factor-1 (IGF-1), brain-derived neurotrophic factor (BDNF)
and others such as Wingless and Int-1 (Wnt) proteins [73].
Most of these molecules act through the Rho GTPases family (Rac1, Cdc42, and RhoA),
which activates the Par3/Par6/aPKC complex [74]; this is essential for neural polarization and axon
specification in the animal kingdom [73–77].
Cell division control protein 42 homolog (Cdc42) and Family Small GTPase 1 (Rac1) participate in
the breakage of cell symmetry during neuritogenesis through the Par6/aPKC complex. Cdc42 activates
Par6. Then, Par6/Par3 activates Rac1 through two guanine nucleotide exchange factors: T-Lymphoma
Invasion-and Metastasis-Inducing Protein 1 (Tiam1) and Sif- And Tiam1-Like Exchange Factor (STEF).
At the same time, Rac1 activates Phosphatidylinositol-4,5-Bisphosphate 3-Kinase (PI3K) and Cdc42,
forming a positive feedback circuit [78] (Figure 2B). Moreover, the activation of Rac1 and Cdc42 leads
to the regrowth of neurites, whereas Ras Homolog Family Member A (RhoA) activation collapses the
growth cone. Persistent activation of Rac1 and Cdc42 leads to the activation of JNK, while activating
Ras Homolog Family Member A (RhoA) leads to its deactivation [79] (Figure 2B). The final effectors
of this pathway are components of the actin and microtubule cytoskeleton, which are essential for
axon specification.
3.2.2. WNT/Frizzled/Disheveled Pathway
The canonical pathway Wnt/β-catenin, and the noncanonical Wnt/planar cell polarity (PCP)
pathway regulate cellular polarization. Wnt ligands bind the family receptor Frizzled, which, in turn,
activates the Dishevelled (Dsv) factors and members of the Rho GTPases family by inhibiting
Glycogen Synthase Kinase (GSK-3β) and activating JNK [80]. Wnt/Frizzled signaling induces
microtubule stabilization.
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Frizzled5 receptors accumulate in lamellipodia during stage 1, and once development reaches
stage 2, the receptor reorders into the phyllopodia. During axon determination, Frizzled5 accumulates
in the axon and is depleted in minor neurites. Thus, the Wnt pathway modulates the transition from
stage 2 to stage 3 during neural polarization trough JNK activation [81].
3.3. Axonogenesis
Evidence that the JNK is indispensable for axonal growth was initially obtained in primary
cultures of embryonic hippocampal neurons by Anthony Oliva and coworkers [82]. They proved that
the pharmacological inhibition of JNK (SP600125) and a dominant-negative construction inhibited axon
growth [82,83]. Their discussion emphasized that kinesin-1, a molecular motor protein that moves
along microtubules, carried molecules for the formation of the signaling complexes needed for axonal
growth (Figure 3). Indeed, it was discovered that kinesin-1 fluctuates between the neurites before axon
determination and concentrates in the axonal growth cone during elongation [84,85]. Now, it has been
shown that Kinesin forms a protein complex with JIP scaffolding proteins, facilitating the diffusion
of relevant cargoes, including BDNF, TrkB [86] and JNK substrate SCG10 [87]. JIP1 and JIP3 recruit
JNK and upstream kinases such as MKK7, DLK [88] and Rho GTPases [89] (Figure 3). Supporting this
data, transgenic knockout Jip-/- and Jip3-/- mice presented aberrations and shrinking of axons in the
commissural tract of the telencephalon during development. Also, the genetic deactivation of either
element of this complex has severe effects in development [90–93].
In addition, Map1b-/- mice phenocopy all effects of null genetics of the Jnk1 and Jip1, suggesting that
the JNK1-JIP1-MAP1B pathway may play a crucial role in axonal growth. The opposite effect was
observed with knockdown for Jip4 in PC12 cells, and evidenced an increase in neurite growth and SCG10
phosphorylation, suggesting that the JNK-JIP4-SCG10 pathway may block axon growth (Figure 3).
Hirai et al., with cultured neurons from double knock-out mice Dlk-/-Jnk1-/-, observed an additive
effect on axon shortening and an amelioration with taxol treatment, which is a chemical component
that promotes the microtubule stabilization. These data supported the notion that DLK-JNK signaling
affects microtubule dynamics through specific substrates. Specifically, the authors found that SCG10
influences the transition between stages 1 and 2. Meanwhile, DCX and MAP2 had a significant effect
between stages 2 and 3 [91]. In vivo studies support the role of DLK and JNK, since deficiencies in
DLX-MKK7-JNK1 signaling leads to defects in axon growth [41,94,95]. The role of JNK1 in these
processes was reinforced with the high turnover of Mkk7 mRNAs in the growth cone, allowing for
high MAP1b phosphorylation through JNK1, and favoring microtubule bundling to increase neurite
outgrowth [39].
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Figure 3. Microtubule (MT) dynamics are regulated by JNK1. (A) MT stability and elongation.
JIP scaffolding proteins and kinesin-1 facilitate the diffusion of JNK1 and the transport of
relevant cargoes needed for axonal growth such as Tiam/Rac, SCG10, BDNF and TrkB receptors.
Unphosphorylated MAP1B and phosphorylated Sthatmin family members by JNK1 promote
microtubule stabilization. Moreover, JNK1 phosphorylates SCG10, resulting on its degradation.
(B) MT shrinkage. The phosphorylation of MAP1B by JNK1 and unphosphorylated SCG10 promote
microtubule depolymerization. In addition, unphosphorylated members of SCG10 proteins sequestrate
tubulin dimers and favor microtubule catastrophe. Adapted from [96].
3.4. Dendritic Organization
3.4.1. Dendritogenesis
Dendritogenesis is the process through which short and dynamic neurites become dendrites
with stable and more prolonged ramifications. Diverse signals control the dendritogenesis process.
For example, SemaphorinA3 regulates dendritic morphology through its Neuropilin1 receptor and
the Thousand and One Amino Acid Protein Kinase 1 and 2 (TAO1/TAO2). In fact, knock-down
expression of Tao2 reduces the number of secondary neurites and affects axonal length in neuron
primary cultures from E18 mice [97]. These effects were like those observed with Bone Morphogenetic
Protein (BMP7). This growth factor acts on dendritogenesis and the stability of microtubules via the
JNK/MAP2 pathway [98]. The Wnt signaling pathway also regulates dendritic arborization. Hence,
the Wnt7b ligand induces dendritogenesis through the Frizzled-7 receptor by downstream activation
of DSV-1-Rac-JNK and Ca2+/calmodulin-dependent protein kinase II (CaMKII) (Figure 2D) [99].
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3.4.2. Dendrite Maintenance
JNK1 is constitutively active in the normal brain and regulates microtubule dynamics through
MAP2 and MAP1B activity. Consequently, Jnk1-/- mice show a loss of microtubule integrity in dendrites
with a progressive degeneration of long nerve fibers [41,100]. In the same line, Jnk1-/- mice display
severe impairment in dendritic arborization in layers 2/3, 4 and 5 of the primary motor cortex [101]
and in cerebellar neurons [102]. This data suggests that dendritic morphology may depend on JNK1
activity. Downstream substrates that may regulate dendrite morphology include SCG10, Macrophage
Myristoylated Alanine-Rich C Kinase Substrate Like-1 (MARCKSL1) or MAP2 (Figure 2D) [101].
Moreover, BDNF-TrkB signaling regulates both dendritic arborization and axonal branching.
BDNF induces the expression of MKP-1 (MAPK phosphatase) by deactivating JNK signaling,
which results in increased microtubule stability. In embryo primary neuron cultures obtained
from Mkp1-/- mice, neurons repress axon branches as a consequence of the persistent phosphorylation
of several JNK substrates (Figure 2E) [103].
4. Neuronal Migration
Neurons originate in specific niches and migrate stereotypically to form nuclei or laminae (cortex
and hippocampus). From their respective niche, NSCs differentiate to neurons and move to a specific
layer through a migratory route. Some paths are relatively short (e.g., cortical glutamatergic neurons),
while others have a long journey (e.g., cortical interneurons) (Figure 4A). Alterations in the migration
mechanism disorganize of the cortical layers, resulting in Neuronal Migration Disorders (NMDs).
Macroscopically, individuals that suffer these alterations manifest mental retardation, intractable




Figure 4. Effects of genetic Jnk1 disabling in the neuronal migration process during cortical embryonic
development in mice. (A) Cortical glutamatergic neurons born in the lateral ventricles (blue).
Cortical interneurons born in the GE (Red) (B) Interneurons from MGE (green) reach the corticostriatal
junction at E12 and invade the subpallium. Interneurons enter to the developing cortex lateromedially
following two migratory tangential streams (i, j). The (i) stream populates the superior layer, while the
(j) stream populates deep layers and hippocampus. Jnk1-/- mice experience severe alterations due to a
delay of entrance and erratic migration of cortical interneurons (k). (C) RG-like cells (red) self-renew and
proliferate by symmetric division: (a-b) RG cells undergo asymmetric division and become migratory
multipolar neurons. (c) Multipolar cells accumulate in IZ and form the MAZ. (d) Multipolar cells
migrate towards the SP and seize radial processes to climb through them toward the pia. They acquire
bipolar morphology. (e) Radial migration ceases and (f) neurons populate the upper (2/3 and 4) and
deep (5 and 6) layers. This radial migration process is altered in Jnk1-/- mice at E18 of development.
The multipolar-to-bipolar phase is faster than in wild-type (WT) (g to h versus a to d). The ventricular
zone is smaller (*) and the cortical layers are disordered (**).
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4.1. Tangential Migration
Cortical inhibitory interneurons emanate in the medial ganglionic eminence (MGE),
caudal ganglionic eminence (CGE), and lateral ganglionic eminence (LGE) [105,106].
Interneurons from MGE reach the corticostriatal junction in mice at a single day of development
(E12.5), invading the subpallium through the marginal zone (MZ) and the intermediate zone (IZ).
As they enter the cortex, neurons migrate tangentially (orthogonal) to the subventricular zone. Then,
they undergo a change direction to populate cortical layers (Figure 4B, upper panel) [106,107]. However,
in Jnk1-/- mice, these migratory neurons delay their entrance to the subpallium, impairing migration
of cortical interneurons (Figure 4B, bottom panel) as occurred with radial migration (Figure 4C).
These observations were achieved by labelling interneurons with Green Fluorescence Protein (GFP)
under control of the Distal-less Homeobox-(Dlx5/6) promoter and recording live brain slices. Jnk1-/- mice
showed the most dominant effect, but double Jnk1-/-Jnk2-/+ and tripe conditional Jnkflox/floxJnk2-/-Jnk3-/-
knock-out mice show exacerbated migratory defects at E13 [108,109].
Remarkably, in the late stages of development (E15), migratory defects are partially rescued
by an unknown mechanism, and only cortical malformations and mispositioned interneurons are
observed [108].
4.2. Radial Migration
During cortex expansion, glutamatergic new-born neurons from the lateral ventricles arrive at the
deep and upper layers by radial migration, in which neurons grab large membrane projections from
radial glial cells and climb through them towards the pia (Figure 4C, upper panel). When neurons get
into the corresponding layer, they disengage and acquire final polarity [107,110–112]. But early after
birth, progenitors lose basal contact during division and cross the subplate before tethering to the radial
glia process [113]. At E18, Jnk1-/- mice showed an unusual accumulation of neuronal cells in the cortical
and intermediate zone layers, supporting the notion that JNK1 regulates this step of development.
Also, at E18 in Jnk1-/- mice, multipolar neurons accelerated their transition to the bipolar phase with
subsequent pial-directed migration. Finally, at the E18 stage of development, the ventricular zone of
Jnk1-/- mice was thinner, and layers 2, 3 and 4 were disarranged (Figure 4C, bottom panel) [56].
4.3. Intracellular Dynamics of Microtubules in Migratory Neurons
Tangential and radial migration follows three intracellular processes: (1) A transient cytoplasmic
swelling or “cytoplasmic dilation” that extends the leading process in the direction of migration.
(2) The movement of the nucleus toward the cytoplasmic swelling through a small constriction as a
result of traction forces, and (3) Retraction of the cell rear process. Notably, axonogenesis occurs in the
rear process during the bipolar phase of glutamatergic neuron migration, but interneurons first cease
their movement, and then the axon grows. A microtubule network emerges from the centrosome and
Golgi apparatus, supporting this dynamic behavior (Figure 5A) [106].
In cortical cultures, silencing the expression of Jnk1 pauses nuclear translocation but does not
impede cytoplasmic swelling. Additionally, when using inhibitor SP600125, similar results were
observed, and the overexpression of activated JNK1 rescued the phenotype, supporting the idea
that JNK1 is highly relevant in this process [105]. JNK1 might regulate substrates such as DCX and
SGC10; promoting dynamic changes in the microtube network of the leading process (Figure 5A) and
perinuclear cage (Figure 5B). The following evidence supports this idea:
(a) DCX decorates microtubules in the perinuclear cage and the growth cone of the leading process [36].
(b) JNK phosphorylation of Ser332, Thr326 and Thr336 in DCX reduces affinity to microtubules and
causes delayed migration in cortical neuron cultures [36,114].
(c) Phospho-DCX, phosphor-SGC10 and phospho-JNK overlap in the intermediate zone in developing
cortices. Jnk1−/− exhibits reductions in phosphorylation rates at Ser73 of SGC10 in the cortical
layers [115].
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Indeed, a dynamic evaluation of a single migratory interneuron showed that the pharmacological
and genetic inhibition of JNK (SP600125 and Jnkflox/floxJnk2-/-Jnk3-/-, respectively) reduces the ramification
rate of the leading process, delaying nuclei translocation and pausing cytoplasmic dilation. Additionally,





Figure 5. JNK1 regulates the phases of neuronal migration. (A) (1) Initially, the leading process is
extended; (2) Later, the nucleus is pulled forward by the reorganization of microtubules that round the
perinuclear cage; (3) Finally, rear retraction occurs. (B) Magnification of the perinuclear cage formed by
MT. MTs (red and brown) are located around the nucleus (blue). The Centrosome/Golgi apparatus
irradiates MTs toward the nucleus. Several targets of JNK1 are localized in the perinuclear cage (DCX,
WDR62).
5. Synaptogenesis
Adequate synapse function is an essential prerequisite for all neuronal processing, especially for
higher cognitive functions like learning and memory. The process of synapse formation and
maintenance—i.e., “synaptogenesis”—is considered the final step of neuronal polarization [117].
In this step, axonal growth cones navigate through a specific pathway until they come into contact
with the appropriate target cells, and forms boutons. At this point, spines are developed in
dendritic compartments. Boutons and spines are not static elements; they move actively and
alter their morphology continuously, even in the adult brain, reflecting the plastic nature of synaptic
connections [118]. Abnormal synaptic formation is associated with neurological disorders such as
Rett syndromes and Fragile X Down [119]. As mentioned above, JNK signaling through cytoskeleton
proteins regulates the microtubule and actin dynamics necessary for the correct formation of both the
presynaptic and postsynaptic domains (Figures 2E and 6) [58,120]. Different studies have reported
that isoform JNK1 is highly present in both the pre- and post- synaptic compartments [121,122],
supporting its participation in the relevant synaptogenesis steps: (a) axonal terminal and spine
formation; (b) synaptic protein recruitment and structural scaffold formation; and (c) synaptic plasticity
and transmission (Figure 6).
Many reports have described how JNK1 regulates the formation of presynaptic domains (axonal
buttons), through the SGC10 and MAP1B substrates that control microtubule dynamics [58,123–125],
and the postsynaptic domains, through the MKK7 and MARCKSL1 substrates that control actin
assembly [126–128]. JNK1 also regulates the trafficking from the cell soma to the dense core vesicles of
the nerve terminals by phosphorylating synaptotagmin-4 [129]. In addition, the levels of presynaptic
N-methyl-D-aspartate (pre-NMDA) receptors are regulated by JNK1-JIP interaction. These pre-NMDA
receptors facilitate the release of neurotransmitters due to direct interaction between vesicles and
membrane SNARE proteins (Syntaxin and Snap25) [121,130,131].
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At the postsynaptic domain, JNK1 may interact with DCLKs (doublecortin-like kinases, DCLK1 and
DCLK2), which are two close homologs genes of DCX [132,133]. DCLKs suppress the maturation of
synapses, which is an important process for the structural plasticity of dendrites [134]. Moreover,
JNK1 interacts with glutamate receptors and postsynaptic scaffold proteins, such as (NMDA) receptors,
postsynaptic density protein 95 (PSD-95), calcium/calmodulin-dependent protein kinase II (CaMKII)
and GluR2 of the α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor [135,136].
These interactions promote receptor clustering during synaptic transmission and synaptic plasticity.
Figure 6. Synaptogenesis is controlled by JNK1. (A) Synaptogenesis occurs during neuronal
differentiation. (B) The presynaptic (axon terminal) and postsynaptic domains (spine formation)
are formed through the regulation of SGC10, MAP1B and MARCKSL1 substrates by JNK1. These events
regulate actin (red) and microtubule dynamics (green). (C) Kinesin 1, together with JNK and JIP, control
vesicle and organelle transport (blue), e.g., the formation of postsynaptic density scaffold proteins
(black). (D) During synaptic transmission, the morphology of structures changes under the control of
JNK1 (synaptic plasticity).
A comparison between WT and Jnk1–/– mice supported the hypothesis that JNK1 plays an
important role in synaptic plasticity mechanisms, such as long-term potentiation or depression (LTP or
LTD) or local translation. The induction of metabotropic glutamate receptor (mGluR) activity increases
the phosphorylation of JNK1 substrates, including transcription factors p-c-Jun and p-ATF2 (activating
transcription factor 2), in WT mice, but this did not occur in Jnk1–/– mice [4]. Additionally, it has been
observed that JNK1 activation controls specific protein levels during synaptic plasticity through the
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AP-1 transcription factor. Thus, the JNK1–c-Jun–AP1 pathway is likely involved in the control of the
loss and gain of synapses [137].
In the adult brain, JNK1 may be detected in the presynaptic and postsynaptic regions; it controls
synaptic plasticity by changing synapse morphology through the cytoskeleton or scaffold proteins,
or through protein expression [138,139]. An optogenetic study in adults showed that JNK1 controls
spine motility, retraction and elimination in response to external inputs like stress [140]. In this line,
a reduction in spine density in the apical and basal dendrites of cortical neurons was observed in Jnk1-/-
mice [122]. Finally, a study with Jip1-/- mice showed enhanced memory in hippocampus-dependent
tasks, indicating that JIP1-mediated JNK activation constrains spatial memory [138]. All these data
reinforce the role of JNK1 in maintaining the synaptic plasticity of adult brain [138,139]. This is a
critical component of the neural mechanisms underlying certain types of learning and memory [141].
More concretely, studies with mice reported that when higher levels of hippocampus-dependent
learning occur, JNK1 signaling is upregulated [142]. Moreover, the lack of JNK1 alters the dendritic
arborization in neurons; these types of alterations are seen in psychiatric disorders [101], supporting the
role of JNK1 in the maintenance and formation of synapses, and consequently, in the correct activity of
neural circuits.
6. Conclusions
The evidence gathered in this revision has allowed us to conclude that JNKs, and especially
JNK1, do play a very significant role in the regulation of the development of neuronal structures
during brain development. It seems that JNK1 signaling is responsible for the control of almost all
steps of cell development, starting with the cellular division of NSCs until the final step in which
neurons are established in a specific layer, forming the synaptic neuronal network. Consequently,
negative modulation of JNK1 signaling activity leads to significant alterations, e.g., in the number
of neurons, their morphology, neuron position and circuit connections in different brain areas.
Earlier dysregulation of JNK1 and its cytosolic substrates could have even more detrimental effects in
neurodevelopment. Despite having been proven to be effective in the treatment of affective disorders
and cognitive loss, inhibition of JNK1 may be not suitable as a therapeutic agent in all pathological
conditions. JNK substrates, instead of JNK1 isoforms, could be considered possible therapeutic agents,
thereby avoiding affect JNK1 functions. More studies are needed to better understand the role of JNK
signaling in mental disorders, as both the gain or loss of function of JNK signaling may contribute
to various pathologies. However, restoring JNK activity in order to prevent neurodevelopmental
pathologies is an attractive hypothesis.
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Abbreviations
aPKC atypical Protein Kinase C
BDNF Brain-Derived Neurotrophic Factor
BMP7 Bone Morphogenic Protein 7
BMPR Bone Morphogenic Protein Receptors




DLK Dual Leucine Zipper Kinase 1
Frizzled Wnt receptor
GE Ganglionic eminence
Gαi subunit of heterotrimeric G protein
IZ Intermedial zone
JIP JNK (c-Jun N-terminal kinase)-interacting proteins
JNK1 c-Jun N-terminal kinase 1
LGE lateral ganglionic eminence
LGN Leu-Gly-Asn Partner of Inscuteable (Pins)
MAP1B Microtubule-associated Protein 1B
MAP2 Microtubule-associated Protein 2
MAZ multipolar accumulation zone
MGE medial ganglionic eminence
MKK7 Mitogen-Activated Protein Kinase Kinase 7.
MZ Marginal zone
NRP1 Neuropilin-1
NSC Neural Stem Cells
Numa Nuclear Mitotic Apparatus Protein
Par3 Partitioning Defective 3n(C.Elegans) Homolog
Par6 Partitioning Defective 6 (C.Elegans) Homolog
PI3K Phosphatidylinositol-4: 5-Bisphosphate 3-Kinase
Rac1 Rac Family Small GTPase 1
RacGEFs Guanine Nucleotide Exchange Factors
RG Radial Glial cells
RhoA Ras Homolog Family Member A
SCG10 Superior Cervical Ganglia Neural Specific-10
Sema 3A Semaphorina3A
SP subplate
STEF Sif- And Tiam1-Like Exchange Factor
SVZ subventricular zone
Tiam1 Lymphoma Invasion-and Metastasis-Inducing Protein 1
TrkB Tirosine Kinase Receptor B
V ventricle
VZ ventricular zone
WDR62 WD40-(tryptophan[W]-aspartic[D] dipeptide 40)-Repeated Domain 62 protein.
Wnt Wingless Proteins family member.
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